Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
Hobson
Alex
A
Wessex Cardiac Unit, Southampton University Hospitals NHS Trust, Southampton SO16 6YD, UK.
Curzen
Nick
N
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D000077144:Clopidogrel; D054855:Drug-Eluting Stents; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010979:Platelet Function Tests; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D018570:Risk Assessment; D015607:Stents; D013916:Thrombelastography; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin